| 臺大學術典藏 |
2021-10-14T02:46:22Z |
Effect of percent free prostate-specific antigen measurement on improving the specificity of serum prostate-specific antigen testing in Taiwanese patients
|
Liao C.-H.; Liu S.-P.; Pu Y.-S.; CHAO-YUAN HUANG; Yu H.-J.; Chen J. |
| 臺大學術典藏 |
2021-10-14T02:45:58Z |
Quinolone prophylaxis in transrectal ultrasound guided prostate biopsy: An eight-year single center experience
|
Chiang B.-J.; Pu Y.S.; Chung S.-D.; Liu S.-P.; Yu H.-J.; Wang S.-M.; Chang H.-C.; Chiang I.-N.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2021-10-14T02:45:47Z |
Benign prostatic enlargement is not associated with diabetes: A population-based study
|
Chiu Y.L.; Kao S.; Lin H.C.; Liu S.P.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2021-10-14T02:45:46Z |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Wang Y.-J.; CHAO-YUAN HUANG; Hou W.-H.; Wang C.-C.; Lan K.-H.; Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-10-14T02:45:45Z |
Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
|
Wang Y.-J.; CHAO-YUAN HUANG; Hou W.-H.; Wang C.-C.; Lan K.-H.; Yu H.-J.; Lai M.-K.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-10-14T02:45:44Z |
Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
|
Hou W.-H.; CHAO-YUAN HUANG; Wang C.-C.; Lan K.-H.; Chen C.-H.; Yu H.-J.; Liu S.-P.; Lai M.-K.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-10-14T02:45:27Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Hung S.-C.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2021-10-14T02:45:22Z |
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
|
Cheng Y.-T.; CHAO-YUAN HUANG; Chen C.-H.; Chiu S.-T.; Hong J.-H.; Pu Y.-S.; Liu S.-P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Chiang I.-N.; Hung S.-C.; Chiang C.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:47Z |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; Lan K.-H.; Chen C.-H.; Yu H.-J.; Lai M.-K.; ANN-LII CHENG; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-08-23T01:35:59Z |
Effects of diabetes on female voiding behavior
|
Lee W.-C.; HUEY-PEIR WU; Tai T.-Y.; Liu S.-P.; Chen J.; Yu H.-J. |
| 臺大學術典藏 |
2021-08-23T01:35:58Z |
Unrecognized Voiding Difficulty in Female Type 2 Diabetic Patients in the Diabetes Clinic: A prospective case-control study
|
Yu H.-J.; Lee W.-C.; Liu S.-P.; Tai T.-Y.; HUEY-PEIR WU; Chen J. |
| 臺大學術典藏 |
2021-08-03T03:49:11Z |
The combination of blood flow velocity and vascular diameter: The Arterial Flow Index is a better parameter in the evaluation of arteriogenic erectile dysfunction
|
Huang, W-L.; Tung, S-Y; CHI-SHIN TSENG; Wang, T-D; Lee, W-J; Liu, S-P; Hsieh, J-T; Chang, H-C; Chang, Y-K |
| 臺大學術典藏 |
2021-08-02T02:32:51Z |
Laparoendoscopic single-site (LESS) retroperitoneal partial adrenalectomy using a custom-made single-access platform and standard laparoscopic instruments: Technical considerations and surgical outcomes
|
Ho C.-H.; Liao P.-W.; Lin V.C.; Jaw F.-S.; SHIH-CHIEH CHUEH; Chung S.-D.; Liu S.-P.; Tsai Y.-C.; Yu H.-J. |
| 臺大學術典藏 |
2021-07-06T07:01:23Z |
A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway
|
Hsu J.-L.; Liu S.-P.; Lee C.-C.; LIH-CHING HSU; Ho Y.-F.; Huang H.-S.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:22Z |
Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway
|
Ho C.-H.; Hsu J.-L.; Liu S.-P.; LIH-CHING HSU; Chang W.-L.; Chao C.C.-K.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:19Z |
Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: The role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways
|
Leu W.-J.;Swain S.P.;Chan S.-H.;Hsu J.-L.;Liu S.-P.;Chan M.-L.;Yu C.-C.;Lih-Ching Hsu;Chou Y.-L.;Chang W.-L.;Hou D.-R.;Guh J.-H.; Leu W.-J.; Swain S.P.; Chan S.-H.; Hsu J.-L.; Liu S.-P.; Chan M.-L.; Yu C.-C.; LIH-CHING HSU; Chou Y.-L.; Chang W.-L.; Hou D.-R.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:18Z |
Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways
|
Chan M.-L.; Yu C.-C.; Hsu J.-L.; Leu W.-J.; Chan S.-H.; LIH-CHING HSU; Liu S.-P.; Ivantcova P.M.; Dogan ?.; Br?se S.; Kudryavtsev K.V.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:16Z |
Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems
|
Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Lih-Ching Hsu;Liu S.-P.;Guh J.-H.; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; LIH-CHING HSU; Liu S.-P.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:16Z |
Para-toluenesulfonamide induces anti-tumor activity through Akt-dependent and -independent mTOR/p70S6K pathway: Roles of lipid raft and cholesterol contents
|
Hsu J.-L.; Leu W.-J.; LIH-CHING HSU; Liu S.-P.; Zhong N.-S.; Guh J.-H. |
| 臺大學術典藏 |
2021-07-06T07:01:14Z |
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
|
Hsu J.-L.; Leu W.-J.; LIH-CHING HSU; Ho C.-H.; Liu S.-P.; Guh J.-H. |
| 臺大學術典藏 |
2021-06-29T03:58:34Z |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Chia-Chun Wang; Lan K.-H.; Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-29T03:58:34Z |
Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
|
Hou W.-H.; Huang C.-Y.; Chia-Chun Wang; Lan K.-H.; Chen C.-H.; Yu H.-J.; Liu S.-P.; Lai M.-K.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-29T03:58:34Z |
Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Chia-Chun Wang; Lan K.-H.; Yu H.-J.; Lai M.-K.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-28T06:52:26Z |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; KENG-HSUEH LAN; Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-28T06:52:25Z |
Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; KENG-HSUEH LAN; Yu H.-J.; Lai M.-K.; Liu S.-P.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-28T06:52:24Z |
Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
|
Hou W.-H.; Huang C.-Y.; Wang C.-C.; KENG-HSUEH LAN; Chen C.-H.; Yu H.-J.; Liu S.-P.; Lai M.-K.; Pu Y.-S.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-06-02T05:43:40Z |
A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway
|
Hsu J.-L.; Liu S.-P.; Lee C.-C.; Hsu L.-C.; Ho Y.-F.; Huang H.-S.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:37Z |
A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase i
|
Yu C.-C.; Pan S.-L.; Chao S.-W.; Liu S.-P.; Hsu J.-L.; Yang Y.-C.; Li T.-K.; Huang W.-J.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:35Z |
Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway
|
Ho C.-H.; Hsu J.-L.; Liu S.-P.; Hsu L.-C.; Chang W.-L.; Chao C.C.-K.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:34Z |
KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora a activity
|
Yu C.-C.; Liu S.-P.; Hsu J.-L.; Hsu J.T.A.; Kudryavtsev K.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:32Z |
Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: The role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways
|
Leu W.-J.; Swain S.P.; Chan S.-H.; Hsu J.-L.; Liu S.-P.; Chan M.-L.; Yu C.-C.; Hsu L.-C.; Chou Y.-L.; Chang W.-L.; Hou D.-R.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:30Z |
Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways
|
Chan M.-L.; Yu C.-C.; Hsu J.-L.; Leu W.-J.; Chan S.-H.; Hsu L.-C.; Liu S.-P.; Ivantcova P.M.; Dogan ?.; Br?se S.; Kudryavtsev K.V.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:27Z |
Para-toluenesulfonamide induces anti-tumor activity through Akt-dependent and -independent mTOR/p70S6K pathway: Roles of lipid raft and cholesterol contents
|
Hsu J.-L.; Leu W.-J.; Hsu L.-C.; Liu S.-P.; Zhong N.-S.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:26Z |
Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems
|
Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Hsu L.-C.;Liu S.-P.;Jih-Hwa Guh; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; Hsu L.-C.; Liu S.-P.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:17Z |
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
|
Hsu J.-L.;Leu W.-J.;Hsu L.-C.;Ho C.-H.;Liu S.-P.;Jih-Hwa Guh; Hsu J.-L.; Leu W.-J.; Hsu L.-C.; Ho C.-H.; Liu S.-P.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-05-25T07:42:09Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; YI-KAI CHANG; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Hung S.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2021-05-25T07:42:08Z |
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
|
Cheng Y.-T.; Huang C.-Y.; Chen C.-H.; Chiu S.-T.; Hong J.-H.; Pu Y.-S.; Liu S.-P.; Lu Y.-C.; YI-KAI CHANG; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Chiang I.-N.; Hung S.-C.; Chiang C.-H. |
| 臺大學術典藏 |
2021-03-18T02:03:43Z |
Metastatic yolk sac tumor of the corpus cavernosum of the penis
|
Hsieh J.-T.; Liu S.-P.; CHIA-TUNG SHUN; Lai M.-K. |
| 臺大學術典藏 |
2021-03-18T02:03:08Z |
Leiomyoma of the corpus cavernosum of the penis
|
Liu S.-P.; CHIA-TUNG SHUN; Chang S.-J.; Chen J.; Hsieh J.-T. |
| 臺大學術典藏 |
2021-03-03T03:01:12Z |
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms
|
Ho C.-H.;Chang T.-C.;Ho-Hsiung Lin;Liu S.-P.;Huang K.-H.;Yu H.-J.; Ho C.-H.; Chang T.-C.; HO-HSIUNG LIN; Liu S.-P.; Huang K.-H.; Yu H.-J. |
| 臺大學術典藏 |
2021-02-02T07:50:58Z |
Psoriasis and the risk of pneumonia: A population-based study
|
Kao L.-T.; Lee, Cha-Ze; Liu S.-P.; Tsai M.-C.; Lin H.-C. |
| 臺大學術典藏 |
2021-02-02T00:47:13Z |
Renal hemodynamics in patients with obstructive uropathy evaluated by duplex doppler sonography
|
Chen J.-H.;Yeong-Shiau Pu;Liu S.-P.;Chiu T.-Y.; Chen J.-H.; YEONG-SHIAU PU; Liu S.-P.; Chiu T.-Y. |
| 臺大學術典藏 |
2021-02-02T00:47:07Z |
Effect of percent free prostate-specific antigen measurement on improving the specificity of serum prostate-specific antigen testing in Taiwanese patients
|
Liao C.-H.;Liu S.-P.;Yeong-Shiau Pu;Huang C.-Y.;Yu H.-J.;Chen J.; Liao C.-H.; Liu S.-P.; YEONG-SHIAU PU; Huang C.-Y.; Yu H.-J.; Chen J. |
| 臺大學術典藏 |
2021-02-02T00:46:48Z |
Choosing the ideal length of a double-pigtail ureteral stent according to body height: Study based on a chinese population
|
Ho C.-H.;Huang K.-H.;Chen S.-C.;Yeong-Shiau Pu;Liu S.-P.;Yu H.-J.; Ho C.-H.; Huang K.-H.; Chen S.-C.; YEONG-SHIAU PU; Liu S.-P.; Yu H.-J. |
| 臺大學術典藏 |
2021-02-02T00:46:34Z |
Quinolone prophylaxis in transrectal ultrasound guided prostate biopsy: An eight-year single center experience
|
Chiang B.-J.; YEONG-SHIAU PU; Chung S.-D.; Liu S.-P.; Yu H.-J.; Wang S.-M.; Chang H.-C.; Chiang I.-N.; Huang C.-Y. |
| 臺大學術典藏 |
2021-02-02T00:46:30Z |
Prediabetes Is Associated with an Increased Risk of Testosterone Deficiency, Independent of Obesity and Metabolic Syndrome
|
Ho C.-H.; Yu H.-J.; Wang C.-Y.; Jaw F.-S.; Hsieh J.-T.; Liao W.-C.; YEONG-SHIAU PU; Liu S.-P. |
| 臺大學術典藏 |
2021-02-02T00:46:17Z |
The outcome and prognostic factors for lymph node recurrence after node-sparing definitive external beam radiotherapy for localized prostate cancer
|
Wang Y.-J.;Huang C.-Y.;Hou W.-H.;Wang C.-C.;Lan K.-H.;Chen C.-H.;Yu H.-J.;Lai M.-K.;Cheng A.-L.;Liu S.-P.;Yeong-Shiau Pu;Cheng J.C.-H.; Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; Lan K.-H.; Chen C.-H.; Yu H.-J.; Lai M.-K.; Cheng A.-L.; Liu S.-P.; YEONG-SHIAU PU; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-02-02T00:46:16Z |
Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
|
Wang Y.-J.; Huang C.-Y.; Hou W.-H.; Wang C.-C.; Lan K.-H.; Yu H.-J.; Lai M.-K.; Liu S.-P.; YEONG-SHIAU PU; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-02-02T00:46:15Z |
Impact of androgen-deprivation therapy on the outcome of dose-escalation prostate cancer radiotherapy without elective pelvic irradiation
|
Hou W.-H.;Huang C.-Y.;Wang C.-C.;Lan K.-H.;Chen C.-H.;Yu H.-J.;Liu S.-P.;Lai M.-K.;Yeong-Shiau Pu;Cheng J.C.-H.; Hou W.-H.; Huang C.-Y.; Wang C.-C.; Lan K.-H.; Chen C.-H.; Yu H.-J.; Liu S.-P.; Lai M.-K.; YEONG-SHIAU PU; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-02-02T00:46:00Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.;Chiang C.-H.;Yeong-Shiau Pu;Liu S.P.;Lu Y.-C.;Chang Y.-K.;Chang H.-C.;Huang K.-H.;Lee Y.-J.;Chow P.-M.;Hung S.-C.;Huang C.-Y.; Cheng Y.-T.; Chiang C.-H.; YEONG-SHIAU PU; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; Chow P.-M.; Hung S.-C.; Huang C.-Y. |
